Although the ideas I share with you all revolve around currency pairs, I thought I'd share another specialty of mine: Biotech and pharma stock. If you're in the field, you may have already heard about Gilead having one of the best price to earning ratio of the major biotech companies. You may have also noticed the sharp decline that they experienced in the summer...
Being with this ticker for awhile I've been through the ups and downs. I outlined a few areas where we see run ups and blowoff tops. It's my estimation that we get a 15 10 20% haircut at times with the blowoff. That's the nature of runs maybe? Maybe even more so with spec bio. Anyway I am eyeballing the makings of the bottom of another possible cup and handle...
Long some IBB calls at the 313 area. Expecting 320 area for the short term target where I will close half my position. Leave the other half to attempt a run up to 329 territory.
4 HR MACD and RSI room to grow
XBI, LABU, BIB should slide to the bottom of the channel until End-July. See high moving-average divergence, reconvergence and channel pattern. Short unless something changes.
cup and handle break out. load up bears, you got this one, haha.
Research it. Could be a nice investment. Longing already from 1.00
Sangamo Daily Chart. Weekly Looking good NASDAQ:SGMO
A peek through the trend line looking good and Low float with any type of news catalyst could give this stock wings. I will use a break through $.94 as a confirmation reversal and will add to my position when passing $1.07. MACD cross on daily, RSI rising on daily. Volume will come from any exposure catalyst. A heck of a PT on this stock as well.
PLSE has been bleeding cash for a while now but it has attracted investments from two investors providing cash infusion to help it stay afloat on early February. This is when the stock broke out and has been trending up since then. Even though doom and gloom was predicted for PLSE here on Feb 23 2017 stock has moved up by $7 since then. Yesterday I was expecting a...
Some support at .31 maybe. Big selloff by majority owner Temasek. large downturn
good fundamentals. hoping for reversal, to 2.14-2.2. solid entry, try 1.94/1.2 is 1.61 so around there is perfect for the correction up. best!
There is one useful way to determine when a trend is over and that is using a 50% "speedline" of a move. The decline from $400 in $IBB, the IShares Nasdaq Biotechnology Index Fund back in July 2015 and then tumbled 40% to $240 on February 9th, 2016 and later retested $240 on June 27, 2016. The mid-point of that decline is $320 and a line drawn from...
No position yet. Refer to chart:) If you have any thoughts about this company, please leave in the comments:)
1 trend retest 2 trend-based fibo. bounce zone 3 possible three bottoms (Super Pattern)
12.5.2016- $KBIO currently trading at 4.25. Potential once they receive PRV (Priority Review Voucher) for Benznidazole possibility for trading at $5-6. Stock jumped about $1 due to the Letter to Stakeholders by Dr. Cameron Durrant. I expect this stock to rise. Disclosure: I am long $KBIO SEE MORE: globenewswire.com